220 related articles for article (PubMed ID: 28836002)
21. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
Lopate G; Pestronk A; Al-Lozi M
Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
[TBL] [Abstract][Full Text] [Related]
22. Bortezomib for refractory acute antibody-mediated rejection in kidney transplant recipients: A single-centre case series.
De Sousa-Amorim E; Revuelta I; Diekmann F; Cofan F; Lozano M; Cid J; Palou E; Sole M; Campistol JM; Oppenheimer F
Nephrology (Carlton); 2016 Aug; 21(8):700-4. PubMed ID: 26492594
[TBL] [Abstract][Full Text] [Related]
23. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
Eftimov F; van Schaik I
Curr Opin Neurol; 2013 Oct; 26(5):496-502. PubMed ID: 23852276
[TBL] [Abstract][Full Text] [Related]
24. Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti-rituximab antibodies.
Casertano S; Signoriello E; Rossi F; Di Pietro A; Tuccillo F; Bonavita S; Lus G
Eur J Neurol; 2020 Dec; 27(12):2673-2675. PubMed ID: 32875645
[TBL] [Abstract][Full Text] [Related]
25. Fludarabine in the Treatment of Refractory Chronic Inflammatory Demyelinating Neuropathies.
Leitch MM; Sherman WH; Brannagan TH
J Clin Neuromuscul Dis; 2015 Sep; 17(1):1-5. PubMed ID: 26301372
[TBL] [Abstract][Full Text] [Related]
26. Chronic inflammatory demyelinating polyneuropathy: a 6-year retrospective clinical study of a hospital-based population.
Rentzos M; Anyfanti C; Kaponi A; Pandis D; Ioannou M; Vassilopoulos D
J Clin Neurosci; 2007 Mar; 14(3):229-35. PubMed ID: 17258131
[TBL] [Abstract][Full Text] [Related]
27. A new treatment regimen with high-dose and fractioned immunoglobulin in a special subgroup of severe and dependent CIDP patients.
Debs R; Reach P; Cret C; Demeret S; Saheb S; Maisonobe T; Viala K
Int J Neurosci; 2017 Oct; 127(10):864-872. PubMed ID: 27918219
[TBL] [Abstract][Full Text] [Related]
28. Bortezomib-associated demyelinating neuropathy--clinical and pathologic features.
Thawani SP; Tanji K; De Sousa EA; Weimer LH; Brannagan TH
J Clin Neuromuscul Dis; 2015 Jun; 16(4):202-9. PubMed ID: 25996966
[TBL] [Abstract][Full Text] [Related]
29. Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up.
Jann S; Bramerio MA; Facchetti D; Sterzi R
J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):70-3. PubMed ID: 18768571
[TBL] [Abstract][Full Text] [Related]
30. Unconventional treatments for chronic inflammatory demyelinating polyneuropathy.
Rajabally YA
Neurodegener Dis Manag; 2017 Oct; 7(5):331-342. PubMed ID: 29043889
[TBL] [Abstract][Full Text] [Related]
31. Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases.
Kuwabara S; Misawa S; Mori M; Tamura N; Kubota M; Hattori T
J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):66-70. PubMed ID: 16361595
[TBL] [Abstract][Full Text] [Related]
32. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.
Dong C; Greathouse KM; Beacham RL; Palladino SP; Helton ES; Ubogu EE
Exp Neurol; 2017 Jun; 292():35-45. PubMed ID: 28215575
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of intravenous immunoglobulin in CIDP.
Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
[TBL] [Abstract][Full Text] [Related]
34. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.
Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP
Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859
[TBL] [Abstract][Full Text] [Related]
35. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
Gorson KC; Natarajan N; Ropper AH; Weinstein R
Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
[TBL] [Abstract][Full Text] [Related]
36. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
[TBL] [Abstract][Full Text] [Related]
37. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
38. Nerve Ultrasound and Electrophysiology for Therapy Monitoring in Chronic Inflammatory Demyelinating Polyneuropathy.
Kerasnoudis A; Pitarokoili K; Gold R; Yoon MS
J Neuroimaging; 2015; 25(6):931-9. PubMed ID: 26242571
[TBL] [Abstract][Full Text] [Related]
39. Treatment of chronic inflammatory demyelinating polyneuropathy with high dose intravenous methylprednisolone monthly for five years: 10-Year follow up.
Börü ÜT; Erdoğan H; Alp R; Taşdemir M; Yıldırım S; Bilgiç A; Duman A; Arslan A
Clin Neurol Neurosurg; 2014 Mar; 118():89-93. PubMed ID: 24529237
[TBL] [Abstract][Full Text] [Related]
40. Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy.
D'Amico A; Catteruccia M; De Benedetti F; Vivarelli M; Colucci M; Cascioli S; Bertini E
Eur J Paediatr Neurol; 2012 May; 16(3):301-3. PubMed ID: 21903431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
